Company: EUDAW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001493152-25-011729
Chunk: 25

Company: EUDA Health Holdings Ltd
Filing Date: 2025-08-08
Form: 424B5
Chunk 25
---
 S-17 |

4. block trades in which the broker-dealer will attempt to sell the shares as agent, but may position and resell a portion of the block as principal to facilitate the transaction;

5. purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

6. an exchange distribution in accordance with the rules of the applicable exchange;

7. privately negotiated transactions;

8. short sales effected after the date the registration statement of which this prospectus is a part is declared effective by the SEC;

9. through the writing or settlement of options or other hedging transactions, whether through an options exchange or otherwise; and

10. in any combination of the above or by any other legally available means.

The Investor may, from time to time, pledge or grant a security interest in some of the Ordinary Shares issued upon conversion of the Convertible Notes and, if the Investor defaults in the performance of its secured obligations, the pledgees or secured parties may offer and sell such Ordinary Shares, from time to time, under this prospectus, or under an amendment or supplement to this prospectus to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus. In connection with the sale of any such Ordinary Shares or interests therein, the Investor may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of our common stock in the course of hedging the positions they assume. The Investor may also sell our common stock short and deliver any such Ordinary Shares to close out their short positions.

The Investor also may resell the Ordinary Shares issued upon conversion of the Convertible Notes in open market transactions in reliance upon Rule 144 under the Securities Act, provided that it meets the criteria and conforms to the requirements of that Rule, or pursuant to other available exemptions from the registration requirements of the Securities Act.

The transfer agent for our Ordinary Shares is Equiniti Trust Company, LLC, EQ, Shareowner Services, or any of their affiliates.

<div align='center'>LEGAL MATTERS</div>

The validity of the Convertible Note and underlying Ordinary Shares and other legal matters as to British Virgin Islands law will be passed upon for us Conyers. Loeb & Loeb LLP, New York, New York, will be passing on matters of United States law for us with respect to the securities offered hereby.

<div align='center'>EXPERTS</div>

The consolidated financial statements of our Company appearing in our annual report on